These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 21487088

  • 21. Tardive dyskinesia caused by tetrabenazine.
    LeWitt PA.
    Clin Neuropharmacol; 2013; 36(3):92-3. PubMed ID: 23673911
    [Abstract] [Full Text] [Related]

  • 22. Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review.
    Caroff SN, Aggarwal S, Yonan C.
    J Comp Eff Res; 2018 Feb; 7(2):135-148. PubMed ID: 28965423
    [Abstract] [Full Text] [Related]

  • 23. Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
    Pakkenberg H, Fog R.
    Arch Neurol; 1974 Nov; 31(5):352-3. PubMed ID: 4607088
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H, Chien C, Cole JO.
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    Setter SM, Neumiller JJ, Dobbins EK, Wood L, Clark J, DuVall CA, Santiago A.
    Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181
    [Abstract] [Full Text] [Related]

  • 26. Tardive dyskinesia.
    Clyne KE, Juhl R.
    Am J Hosp Pharm; 1976 May; 33(5):481-6. PubMed ID: 1274963
    [Abstract] [Full Text] [Related]

  • 27. Tardive dyskinesia.
    Teusink JP.
    Am Fam Physician; 1974 May; 9(5):101-5. PubMed ID: 4857228
    [No Abstract] [Full Text] [Related]

  • 28. Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report.
    Palermo G, Mazzucchi S, Unti E, Bonuccelli U, Ceravolo R.
    J Clin Psychopharmacol; 2020 May; 40(6):628-630. PubMed ID: 33136925
    [No Abstract] [Full Text] [Related]

  • 29. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A, Cadeddu F, Guidubaldi A, Piano C, Soleti F, Zinzi P, Bentivoglio AR.
    Clin Neuropharmacol; 2008 May; 31(6):313-8. PubMed ID: 19050408
    [Abstract] [Full Text] [Related]

  • 30. Selecting Treatment for Patients With Tardive Dyskinesia Using Safety and Efficacy Evidence.
    McEvoy JP.
    J Clin Psychiatry; 2020 Sep 29; 81(6):. PubMed ID: 32991793
    [Abstract] [Full Text] [Related]

  • 31. Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study.
    Kertesz DP, Swartz MV, Tadger S, Plopski I, Barak Y.
    Clin Neuropharmacol; 2015 Sep 29; 38(1):23-5. PubMed ID: 25580924
    [Abstract] [Full Text] [Related]

  • 32. Neurotransmitter depleter tetrabenazine; potential candidate for schizophrenia treatment?
    Malik A, Balkoski V.
    Schizophr Res; 2007 Nov 29; 96(1-3):267-8. PubMed ID: 17683910
    [No Abstract] [Full Text] [Related]

  • 33. Persistent phenothiazine dyskinesia treated with tetrabenazine.
    Godwin-Austen RB, Clark T.
    Br Med J; 1971 Oct 02; 4(5778):25-6. PubMed ID: 4938245
    [Abstract] [Full Text] [Related]

  • 34. Valbenazine for Tardive Dyskinesia.
    Freudenreich O, Remington G.
    Clin Schizophr Relat Psychoses; 2017 Oct 02; 11(2):113-119. PubMed ID: 28742396
    [Abstract] [Full Text] [Related]

  • 35. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J.
    Ann Neurol; 1982 Jan 02; 11(1):41-7. PubMed ID: 6460467
    [Abstract] [Full Text] [Related]

  • 36. Effect of tetrabenazine use on restless legs syndrome.
    Ondo WG, Jia JJ.
    Sleep Med; 2010 Oct 02; 11(9):958-9. PubMed ID: 20817597
    [No Abstract] [Full Text] [Related]

  • 37. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Jankovic J.
    Adv Neurol; 1983 Oct 02; 37():277-89. PubMed ID: 6574695
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of Traumatic Brain Injury-Induced Dyskinesia With Tetrabenazine: A Case Report.
    Lauterbach MD, Notarangelo PL, Lane KS, Koliatsos VE.
    Psychosomatics; 2015 Oct 02; 56(5):567-71. PubMed ID: 25591493
    [No Abstract] [Full Text] [Related]

  • 39. Alpha methylparatyrosine and tetrabenazine in movement disorders.
    Lang AE, Marsden CD.
    Clin Neuropharmacol; 1982 Dec 02; 5(4):375-87. PubMed ID: 6130839
    [Abstract] [Full Text] [Related]

  • 40. Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    Gilligan BS, Wodak J, Veale JL, Munro OR.
    Med J Aust; 1972 Nov 04; 2(19):1054-6. PubMed ID: 4264609
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.